INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

April 8, 2022

Period of Report

April 6, 2022

Accession Number

0001062993-22-009998